CG Oncology (CGON) Stock Price
CG Oncology Price
Revenue at CG Oncology has contracted by 21.0% per year over the past 4 years to 4.04 M USD. For CG Oncology, the net margin of -3,985.0% is down versus -124.0% a few years ago. The consensus 12-month price target for CG Oncology is 85.00 USD, about 13.7% above where the stock trades today. Of 21 analysts, 19 rate the stock a buy — an overall Buy consensus.
CG Oncology stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
CG Oncology business model & stock analysis
Frequently asked questions about CG Oncology
Analysts currently set an average price target of 87.20 USD for the CG Oncology stock (median: 85.00 USD), implying +16.7 % versus the latest price. The consensus is based on 21 analyst ratings.
21 analysts currently rate the CG Oncology stock: 19 recommend buying, 2 holding and 0 selling. For 2026, analysts expect CG Oncology to generate revenue of 4.34 M USD and earnings per share of -3.32 USD.
Converted at the current exchange rate, the CG Oncology share trades at 66.81 EUR (74.74 USD).
The expected revenue of CG Oncology is 4.34 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of CG Oncology is -256.47 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of CG Oncology is currently -22.53. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the CG Oncology stock.
The price-to-sales ratio (P/S) of CG Oncology is currently 1,332.52. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the CG Oncology stock.
The Eulerpool Quality Score for CG Oncology is 4/10.
The ISIN of CG Oncology is US1569441009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of CG Oncology is CGON. The ticker symbol is used to trade CG Oncology shares on the stock exchange.
CG Oncology stock
CG Oncology Peer Group
All fundamentals and in-depth analysis of CG Oncology
Our stock analysis for CG Oncology stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CG Oncology. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.